KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Return on Invested Capital (2016 - 2025)

Boston Scientific's Return on Invested Capital history spans 17 years, with the latest figure at 0.25% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 6.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, up 6.0%, while the annual FY2025 figure was 0.13%, 5.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.25% at Boston Scientific, down from 28.09% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 28.09% in Q3 2025 and bottomed at 68.08% in Q2 2025.
  • The 5-year median for Return on Invested Capital is 0.08% (2022), against an average of 1.88%.
  • The largest YoY upside for Return on Invested Capital was 2776bps in 2025 against a maximum downside of -6842bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.07% in 2021, then crashed by -40bps to 0.04% in 2022, then soared by 54bps to 0.07% in 2023, then skyrocketed by 189bps to 0.19% in 2024, then grew by 29bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for BSX's Return on Invested Capital are 0.25% (Q4 2025), 28.09% (Q3 2025), and 68.08% (Q2 2025).